Atlas Trials

Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.

Clinical trial NCT06661317 · UNKNOWN

Trial details

NCT number
NCT06661317
Sponsor
Medical University of Warsaw
Status
UNKNOWN
Study type
OBSERVATIONAL
HIV-1-infectionDRMDRM Gene MutationART
Start date
2024-11-01
Primary completion
2024-11-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.